BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korn EL, Othus M, Chen T, Freidlin B. Assessing treatment efficacy in the subset of responders in a randomized clinical trial. Ann Oncol 2017;28:1640-7. [PMID: 28444115 DOI: 10.1093/annonc/mdx197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Buyse M, Saad ED, Burzykowski T, Péron J. Assessing Treatment Benefit in Immuno-oncology. Stat Biosci 2020;12:83-103. [DOI: 10.1007/s12561-020-09268-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kelleher T, Cai J, Botwood NA, Labriola DF. Characterizing tumor shrinkage as a measure of clinical benefit for immune checkpoint inhibitors. J Immunother Cancer 2021;9:e001177. [PMID: 33558277 DOI: 10.1136/jitc-2020-001177] [Reference Citation Analysis]